SCHEMBL7185895

SCHEMBL7185895

C[C@H](CO)Nc1ncc(C#N)cc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
GLA P06280 2/20 0.42
IRAK4 Q9NWZ3 7/20 0.40
VCAM1 P19320 2/20 0.39
JAK2 O60674 2/20 0.38
JAK3 P52333 2/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KAT2B Q92831 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7183929 0.84 ALDH1A1 (0.42) ALDH1A1GLAIRAK4VCAM1JAK2
SCHEMBL16722232 0.81 ALDH1A1 (0.47) ALDH1A1GLAMAPTLMNACYP1A2
SCHEMBL16722235 0.81 ALDH1A1 (0.47) ALDH1A1GLAMAPTLMNACYP1A2
SCHEMBL25887391 0.78 VCAM1 (0.47) ALDH1A1VCAM1JAK2JAK3MAPT
SCHEMBL30989701 0.78 VCAM1 (0.47) ALDH1A1VCAM1JAK2JAK3MAPT
SCHEMBL7190772 0.78 ALDH1A1 (0.44) ALDH1A1MAPTLMNAPKMCYP1A2
SCHEMBL7190773 0.77 KAT2B (0.52) ALDH1A1VCAM1MAPTLMNAPKM
SCHEMBL7182036 0.77 KAT2B (0.52) ALDH1A1VCAM1MAPTLMNAPKM
SCHEMBL26914256 0.76 GLA (0.41) ALDH1A1GLAVCAM1JAK2JAK3
SCHEMBL26914255 0.76 GLA (0.41) ALDH1A1GLAVCAM1JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6582351-B1 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-24 US disclosed